Skip to main content

This webpage content is intended for Health Care Professionals (HCPs) only.

I am not a HCP

Intended for Healthcare Professionals

Johnson and Johnson logo graphic link
/en-GB
  • biosense webster logo
  • Cerenovus logo
  • DePuy Synthes Logo
  • Ethicon Logo
  • mentor logo

Intended for HCPs

Intended for Healthcare Professionals

Secondary nav block

  • Home
  • Soft Tissue
    • Adjunctive Hemostats
    • Catheter Line Infection Prevention
    • Electrosurgery and Smoke Evacuation
    • Energy Sealing & Dissecting
    • Wound Closure
  • Orthopedics
    • 1.5mm LCP® System
    • Distal Femoral Osteotomy System
    • Double/Triple Pelvic Osteotomy Plates
    • Large Fragment System
    • Mini Fragment System
    • Pancarpel Arthrodesis Plates
    • Power Tools
    • Small Fragment System
    • Tibial Plateau Leveling Osteotomy (TPLO) System
    • Tibial Tuberosity Advancement (TTA)
  • Online Ordering
    • J&J Customer Connect
    • New Acount Registration
  • Contact Us
    • Contact Us
    • Key Contacts
    • Meet the Team
  • Professional Education
    • Book in Professional Education
    • Depuy Synthes Videos
    • Ethicon Education Videos
    • J&J Institute
  • Sustainability

SURGICEL® FIBRILLAR™ Absorbable Hemostat

SURGICEL® FIBRILLAR™ Absorbable Hemostat

The lightweight, layered structure of SURGICEL FIBRILLAR Hemostat “melts” into bleeding tissue and can be used at multiple sites. One layer is more effective than 4 layers of SURGICEL® Original Absorbable Hemostat.1

Request Demo
Instructions for Use

Instructions for use are found in the information that accompanied the product packaging.

View Specs
SURGICEL FIBRILLAR Hemostat box

IMAGES

SURGICEL FIBRILLAR Hemostat box
Ethicon Logo

Features & Benefits

Faster hemostasis

Faster hemostasis

36% faster hemostasis vs SURGICEL Original Hemostat.2 Treatment with SURGICEL FIBRILLAR Hemostat decreased adjunctive hemostatic product usage, intensive care unit (ICU) costs, transfusion costs, and length of stay (LOS).

Versatile adherence

Versatile adherence

Conforms to the site for optimal adherence. Easily separated layers are customizable, allowing for precise placement. The lightweight layers and tufts peel off as much or as little as desired.

Product Specifications

Product Group


Product Code Description  Size  QTY/Box 
1961 Soft, lightweight, layered ORC   1 in x 2 in   10 
1962 Soft, lightweight, layered ORC   2 in x 4 in   10 
1963 Soft, lightweight, layered ORC   4 in x 4 in   10 

References

1. Hutchinson RW, George K, Johns D, Craven L, Zhang G, Shnoda P. Hemostatic efficacy and tissue reaction of oxidized regenerated cellulose hemostats. Cellulose. 2013;20(1):537-545.
2. Harrington CG. Hemostatic effectiveness of SURGICEL NU-KIT®, and SURGICEL® Fibrillar in a swine spleen model Ethicon, Inc.

SURGICEL®  Essential Product Information

INDICATIONS

SURGICEL® Absorbable Hemostat (oxidized regenerated cellulose) is used adjunctively in surgical procedures to assist in the control of capillary, venous, and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective. SURGICEL® ORIGINAL, SURGICEL® FIBRILLAR™, SURGICEL® NU-KNIT®, and SURGICEL® SNoW™ Absorbable Hemostats can be cut to size for use in endoscopic procedures.
 
PRECAUTIONS
Use only as much SURGICEL® Absorbable Hemostat as is necessary for hemostasis, holding it firmly in place until bleeding stops. Remove any excess before surgical closure in order to facilitate absorption and minimize the possibility of foreign body reaction.
In urological procedures, minimal amounts of SURGICEL® Absorbable Hemostat should be used and care must be exercised to prevent plugging of the urethra, ureter, or a catheter by dislodged portions of the product.
Since absorption of SURGICEL® Absorbable Hemostat could be prevented in chemically cauterized areas, its use should not be preceded by application of silver nitrate or any other escharotic
chemicals.
If SURGICEL® Absorbable Hemostat is used temporarily to line the cavity of large open wounds, it should be placed so as not to overlap the skin edges. It should also be removed from open wounds by forceps or by irrigation with sterile water or saline solution after bleeding has stopped.
Precautions should be taken in otorhinolaryngologic surgery to assure that none of the material is aspirated by the patient. (Examples: controlling hemorrhage after tonsillectomy and controlling
epistaxis.)
Care should be taken not to apply SURGICEL® Absorbable Hemostat too tightly when it is used as a wrap during vascular surgery (see Adverse Reactions section of the complete product package insert).
 
ADVERSE EVENTS 
“Encapsulation” of fluid and foreign body reactions have been reported.
 
There have been reports of stenotic effect when SURGICEL® Absorbable Hemostat has been applied as a wrap during vascular surgery.
 
Paralysis and nerve damage have been reported when SURGICEL® Absorbable Hemostat was used around, in, or in proximity to foramina in bone, areas of bony confine, the spinal cord, and/or the optic nerve and chiasm.
 
Blindness has been reported in connection with surgical repair of a lacerated left frontal lobe when SURGICEL® Absorbable Hemostat was placed in the anterior cranial fossa.
 
Possible prolongation of drainage in cholecystectomies and difficulty passing urine per urethra after prostatectomy have been reported. 
 
For more information, please consult your doctor or for product quality and technical questions, call 1-800-795-0012. For complete product information including indications, contraindications,
warnings, precautions, and adverse reactions, please reference the individual product package inserts.

113927-190509

© Johnson & Johnson Medical Limited 2021. All Rights Reserved.

Please refer always to the Instructions for Use / Package Insert that come with the device for the most current and complete instructions.

Johnson & Johnson
Johnson & Johnson
  • 
  • 
  • Privacy Policy
  • Legal Notice
  • Modern Slavery Act Statement
  • Accessibility Statement
  • Contact
  • WEEE Statement
English (United Kingdom & Ireland)

 

All contents © Medical Devices Business Services, Inc. 2021. All Rights Reserved

ROI

Johnson & Johnson Ireland Ltd is compliant with the Waste Electrical & Electronic Equipment (WEEE) Regulations 2014, with Producer Registration Number: [00541WB].  As a producer we are obligated to offer a takeback service for WEEE, we do this on our own behalf using appropriate recycling facilities. For further information, please contact Johnson & Johnson Ireland Ltd on +353 1 466 5200

You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.

Yes, Continue to External Site No, Stay Here